Apixaban versus warfarin in patients with atrial fibrillation

Granger, Christopher B., Alexander, John H., McMurray, John J.V., Lopes, Renato D., Hylek, Elaine M., Hanna, Michael, Al-Khalidi, Hussein R., Ansell, Jack +24 more·2011·New England Journal of Medicine

DOI 10.1056/nejmoa1107039

Cited by (1,013)

Items 501–600 of 1,013

Atrial Fibrillation and Ischemic Stroke: A Clinical Review
Ibrahim Migdady, Andrew Russman, Andrew Blake Buletko · 2021 · Seminars in Neurology
Poststroke atrial fibrillation: Cause or consequence?
Luciano Alberto Sposato, Patricia Mariana Riccio, Vladimir Hachinski · 2014 · Neurology
Targeted Anticoagulation for Atrial Fibrillation Guided by Continuous Rhythm Assessment With an Insertable Cardiac Monitor: The Rhythm Evaluation for Anticoagulation With Continuous Monitoring (REACT.COM) Pilot Study
PASSMAN, ROD, LEONG‐SIT, PETER, ANDREI, ADIN‐CRISTIAN, HUSKIN, ANNA, TOMSON, TODD T., BERNSTEIN, RICHARD, ELLIS, ETHAN, WAKS, JONATHAN W., ZIMETBAUM, PETER · 2016 · Journal of Cardiovascular Electrophysiology
Epicardial left atrial appendage AtriClip occlusion reduces the incidence of stroke in patients with atrial fibrillation undergoing cardiac surgery
Etem Caliskan, Ayhan Sahin, Murat Yılmaz, Burkhardt Seifert, Ricarda Hinzpeter, Hatem Alkadhi, James L. Cox, Tomáš Holubec, Diana Reser, Volkmar Falk et al. · 2017 · EP Europace
Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial
Patrícia O. Guimarães, Sean D. Pokorney, Renato D. Lópes, DANIEL M. WOJDYLA, Bernard John Gersh, Anna Giczewska, Anthony Carnicelli, Basil S. Lewis, Michael Hanna, Lars C. Wallentin et al. · 2019 · Clinical Cardiology
Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study
Amitava Banerjee, Valerio Benedetto, Phillip Gichuru, Jane Burnell, Sotiris Antoniou, RICHARD JOHN SCHILLING, William David Strain, Ronan P. Ryan, Caroline Leigh Watkins, Tom P Marshall et al. · 2019 · Heart
A practical approach to the management of cerebral amyloid angiopathy
Mariel G. Kozberg, Valentina Perosa, M. Edip Gurol, Susanne J. van Veluw · 2020 · International Journal of Stroke
Drug–drug interactions with warfarin: A systematic review and meta‐analysis
Mei Wang, Dena Zeraatkar, Michael Obeda, Munil Lee, Michael Cristian Garcia, Laura Nguyen, Arnav Agarwal, Farah Al‐Shalabi, Harsukh Benipal, Afreen Ahmad et al. · 2021 · British Journal of Clinical Pharmacology
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
Dominik Linz, Jason G. Andrade, Elena Arbelo, Giuseppe Boriani, GÜNTER E. BREITHARDT, A. John Camm, Valeria Caso, Jens Cosedis Nielsen, Mirko De Melis, Tom J. R. De Potter et al. · 2024 · EP Europace
Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays
Claire Flaujac, Xavier Delavenne, Sara Quenet, Marie‐Hélène Horellou, Silvy Laporte, Virginie Siguret, Thomas Lecompte, Isabelle Gouin‐Thibault · 2013 · Thrombosis and Haemostasis
How I treat target-specific oral anticoagulant–associated bleeding
Deborah M. Siegal, David A. Garcia, Mark Andrew Crowther · 2014 · Blood
Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation
Tze‐Fan Chao, Kang-Ling Wang, Chia-Jen Liu, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Ta‐Chuan Tuan, Fa‐Po Chung, Jo‐Nan Liao et al. · 2015 · Journal of the American College of Cardiology
Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation
Joëlle Kefer, Apostolos Tzikas, Xavier Freixa, Samera Shakir, Sameer A. Gafoor, Jens Erik Nielsen‐Kudsk, Sérgio Luis Berti, Gennaro Santoro, Adel Aminian, Ulf Landmesser et al. · 2016 · International Journal of Cardiology
Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy
Brandon William Calenda, Valentı́n Fuster, Jonathan L. Halperin, Christopher Bull Granger · 2016 · Nature Reviews Cardiology
Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants
Rahul Aggarwal, Christian Thomas Ruff, Saverio Virdone, Sylvie Perreault, Ajay K. Kakkar, Michael G. Palazzolo, Marc Dorais, Gloria Kayani, Daniel E. Singer, Eric Alexander Secemsky et al. · 2023 · Circulation
Oral Direct Factor Xa Inhibitors
Calvin H. Yeh, James C. Fredenburgh, Jeffrey Ian Weitz · 2012 · Circulation Research
Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding
Wayne A. Ray, Cecilia P. Chung, Katherine T. Murray, Walter E. Smalley, James R. Daugherty, William D. Dupont, C. Michael Stein · 2016 · Gastroenterology
Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events
Natalia S. Rost, Robert Patrick Giugliano, Christian Thomas Ruff, Sabina A. Murphy, Andrea E. Crompton, Andrew David Norden, Scott B. Silverman, Aneesh B. Singhal, José Carlos Nicolau, Bhupathi SomaRaju et al. · 2016 · Stroke
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy
Renato D. Lópes, Patrícia O. Guimarães, Brad J. Kolls, DANIEL M. WOJDYLA, Cheryl Bushnell, Michael Hanna, J. Donald Easton, Laine Elliott Thomas, Lars C. Wallentin, Sana M. Al‐Khatib et al. · 2017 · Blood
Silent brain infarcts impact on cognitive function in atrial fibrillation
Michael Kühne, Philipp Krisai, Michael Coslovsky, Nicolas Rodondi, Andreas S. Müller, Jürg Hans Beer, Peter Ammann, Angelo Auricchio, Giorgio Moschovitis, Daniel Hayoz et al. · 2022 · European Heart Journal
Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
Vanessa Roldán, Francisco R. Marín, Sergio Manzano‐Fernández, Hermógenes Fernández, Pilar Gallego, Mariano Valdés, Vicente Vicente, Gregory Y.H. Lip · 2013 · Thrombosis and Haemostasis
Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation
Chris G Cameron, Doug Coyle, Trevor A. Richter, Shannon Kelly, Kasandra Gauthier, Sabine Steiner, Marc Carrier, Kathryn Coyle, Annie Bai, Kristen Moulton et al. · 2014 · BMJ Open
Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin
Matthew J. Price, Vivek Yerrapu Reddy, Miguel Valderrábano, Jonathan L. Halperin, Douglas N Gibson, Nicole T. Gordon, Kenneth Christopher Huber, David R. Holmes · 2015 · JACC: Cardiovascular Interventions
Perioperative management of patients on direct oral anticoagulants
Virginie Dubois, Anne-Sophie Dincq, Jonathan Douxfils, Brigitte Ickx, Charles Marc Samama, Jean‐Michel Dogné, Maximilien J. Gourdin, Bernard Châtelain, François Mullier, Sarah Lessire · 2017 · Thrombosis Journal
Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs)
Paolo Gelosa, Laura Castiglioni, Marco Tenconi, Ludovico Baldessin, Giorgio Racagni, Alberto Corsini, Stefano Bellosta · 2018 · Pharmacological Research
Treatment of bleeding complications in patients on anticoagulant therapy
Piran, Siavash, Schulman, Sam · 2019 · Blood
Newer oral anticoagulants: A review of laboratory monitoring options and reversal agents in the hemorrhagic patient
Marta A. Miyares, Kyle Davis · 2012 · American Journal of Health-System Pharmacy
Systematic Review and Adjusted Indirect Comparison Meta-Analysis of Oral Anticoagulants in Atrial Fibrillation
William L. Baker, Olivia J Phung · 2012 · Circulation Cardiovascular Quality and Outcomes
Efficacy and Safety of Rivaroxaban in Patients With Heart Failure and Nonvalvular Atrial Fibrillation
Sean van Diepen, Anne S. Hellkamp, Manesh R. Patel, Richard Clinton Becker, GÜNTER E. BREITHARDT, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer et al. · 2013 · Circulation Heart Failure
Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention
Jason G. Andrade, Andrew David Krahn, Allan Cameron Skanes, Daniel M. Purdham, Antonio Ciaccia, Sean P. Connors · 2015 · Canadian Journal of Cardiology
Patient Preferences for Oral Anticoagulation Therapy in Atrial Fibrillation: A Systematic Literature Review
Thomas Wilke, Sabine Bauer, S. Mueller, Thomas Kohlmann, Rupert Martin Bauersachs · 2016 · Patient
Safety and effectiveness of apixaban compared to warfarin in dialysis patients
Daniel R. Reed, Surabhi Palkimas, Rebecca Haynes Hockman, Sumner Abraham, Tri Minh Le, Hillary S. Maitland · 2018 · Research and Practice in Thrombosis and Haemostasis
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight
Stefan Hans Hohnloser, Marat Fudim, John Hunter Alexander, DANIEL M. WOJDYLA, Justin Adrian Ezekowitz, Michael Hanna, Dan Atar, Ziad Hijazi, Maria Cecilia Bahit, Sana M. Al‐Khatib et al. · 2019 · Circulation
Trends in anticoagulant prescribing: a review of local policies in English primary care
Katherine H. Ho, Maria van Hove, Gillian C. Leng · 2020 · BMC Health Services Research
Practical Management of Anticoagulation in Patients With Atrial Fibrillation
Richard J. Kovacs, Greg C. Flaker, Sherry J. Saxonhouse, John U. Doherty, Kim K. Birtcher, Adam C. Cuker, Bruce L. Davidson, Robert Patrick Giugliano, Christopher Bull Granger, Amir K. Jaffer et al. · 2015 · Journal of the American College of Cardiology
Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial
Kuan H. Ng, Olga Shestakovska, Stuart J. Connolly, John W. Eikelboom, Álvaro Avezum, Rafael Díaz, Fernando Tomas Lanas, Salim Yusuf, Robert G. Hart · 2015 · Age and Ageing
Recent advances in spontaneous intracerebral hemorrhage
Ravi Garg, José Biller · 2019 · F1000Research
STS/SCA/AmSECT/SABM Update to the Clinical Practice Guidelines on Patient Blood Management
Pierre R. Tibi, Robert Scott McClure, Jiapeng Huang, Robert A. Baker, David C Fitzgerald, C. David Mazer, Marc E. Stone, Danny Chu, Alfred H. Stammers, Tim Dickinson et al. · 2021 · Journal of Cardiothoracic and Vascular Anesthesia
Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial
Ronny Alcalai, Adi Butnaru, Gil Moravsky, Oren Yagel, Razek Rashad, Mahsati Ibrahimli, David Planer, Offer Amir, Gabby Elbaz‐Greener, David W. Leibowitz · 2021 · European Heart Journal - Cardiovascular Pharmacotherapy
Evolving Treatments for Arterial and Venous Thrombosis
Noel Chan, John W. Eikelboom, Jeffrey Ian Weitz · 2016 · Circulation Research
Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation
Azmil H. Abdul‐Rahim, Ana Cristina Perez Moreno, Rachael L. Fulton, Pardeep S. Jhund, Roberto Latini, Gianni Tognoni, John Wikstrand, JOHN K. KJEKSHUS, Gregory Y.H. Lip, Aldo Pietro Maggioni et al. · 2015 · Circulation
Pharmacokinetic and Pharmacodynamic Drug Interactions With New Oral Anticoagulants
Thaddaus R. Hellwig, Michael P. Gulseth · 2013 · Annals of Pharmacotherapy
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion
Bernhard Meier, Yuri Blaauw, Ahmed Aziz Khattab, Torsten Lewalter, Horst Sievert, Claudio Tondo, Michael Glikson · 2015 · EuroIntervention
Periprocedural Intracardiac Echocardiography for Left Atrial Appendage Closure
Sérgio Luis Berti, Umberto Paradossi, Francesco Meucci, Giuseppe Trianni, Apostolos Tzikas, Marco Rezzaghi, Miroslava Stolkova, Cataldo Palmieri, Fabio Mori, Gennaro Santoro · 2014 · JACC: Cardiovascular Interventions
Non‐adherence to new oral anticoagulants: a reason for concern during long‐term anticoagulation?
Rosendo A. Rodriguez, Marc Carrier, Philip Stephen Wells · 2012 · Journal of Thrombosis and Haemostasis
Trends in Oral Anticoagulant Choice for Acute Stroke Patients with Nonvalvular Atrial Fibrillation in Japan: The SAMURAI-NVAF Study
Ḱazunori Toyoda, Shoji Arihiro, Kenichi Todo, Hiroshi Yamagami, Kazumi Kimura, Eisuke Furui, Tadashi Terasaki, Yoshiaki Shiokawa, Kenji Kamiyama, Shunya Takizawa et al. · 2015 · International Journal of Stroke
Management of cardiovascular disease in patients with kidney disease
Mark R. Kahn, Michael J. Robbins, Michael C. Kim, Valentı́n Fuster · 2013 · Nature Reviews Cardiology
Comparisons between Novel Oral Anticoagulants and Vitamin K Antagonists in Patients with CKD
Ziv Harel, Michelle Sholzberg, Prakesh S. Shah, Katerina Pavenski, Shai Harel, Ron Wald, Chaim M. Bell, Jeffrey M. Perl · 2014 · Journal of the American Society of Nephrology
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial
Tze‐Fan Chao, Shih‐Ann Chen, Christian Thomas Ruff, Rose A. Hamershock, Michele F. Mercuri, Elliott Marshall Antman, Eugene Braunwald M. D, Robert Patrick Giugliano · 2018 · European Heart Journal
Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population
Tae‐Hoon Kim, Pil‐Sung Yang, Hee Tae Yu, Eunsun Jang, Hye Jung Shin, Ha Yan Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Jung‐Hoon Sung, Hui‐Nam Pak et al. · 2018 · European Heart Journal
Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation
David Julian Seiffge, Maurizio Paciaroni, Duncan Wilson, Masatoshi Koga, Kosmas Macha, Manuel Cappellari, Sabine A. Schaedelin, Clare Shakeshaft, Masahito Takagi, Georgios K. Tsivgoulis et al. · 2019 · Annals of Neurology
Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation
Daehoon Kim, Jae‐Sun Uhm, Eue‐Keun Choi, Il-Young Oh, Jun Kim, Young Soo Lee, Junbeom Park, Jum Suk Ko, Kyoung‐Min Park, Jung‐Hoon Sung et al. · 2025 · JAMA
Direct Oral Anticoagulants
Jerrold H. Levy, Alex C. Spyropoulos, Charles Marc Samama, James Demetrios Douketis · 2014 · JACC: Cardiovascular Interventions
Anticoagulation in atrial fibrillation
Benjamin Adam Steinberg, Jonathan Paul Piccini · 2014 · BMJ
Major bleeding risk among non‐valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real‐world” observational study in the United States
Gregory Y.H. Lip, Xianying Pan, Shital Kamble, Hugh Kawabata, Jack Mardekian, Cristina Masseria, Amanda S. Bruno, Hemant M. Phatak · 2016 · International Journal of Clinical Practice
The Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO) trial
David R. Holmes, Vivek Yerrapu Reddy, Maurice Buchbinder, Kenneth M. Steín, Myriah Elletson, Martin Bergmann, Boris Schmidt, Jacqueline Saw · 2017 · American Heart Journal
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Karsten Bruins Slot, Eivind Berge · 2013 · Cochrane Database of Systematic Reviews
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018
David B. Brieger, John V. Amerena, John Attia, Beata V. Bajorek, Kim Hoe Chan, Cia Connell, Ben Freedman, Caleb Ferguson, Tanya L Hall, Haris M. Haqqani et al. · 2018 · The Medical Journal of Australia
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke
Antonio Greco, Giovanni Occhipinti, Daniele Giacoppo, Federica Giuseppa Agnello, Claudio Laudani, Marco Spagnolo, Maria Sara Mauro, Carla Rochira, Simone Finocchiaro, Placido Maria Mazzone et al. · 2023 · Journal of the American College of Cardiology
How to define valvular atrial fibrillation?
Laurent Fauchier, Raphaël Philippart, Nicolas Clémenty, Thierry Bourguignon, Denis Angoulvant, Fabrice Ivanés, Dominique Babuty, Anne Bernard · 2015 · Archives of cardiovascular diseases
Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease
John W. Eikelboom, Stuart J. Connolly, Peggy Gao, Ernesto Paolasso, Raffaele De Caterina, Steen Husted, Martin James O'Donnell, Salim Yusuf, Robert G. Hart · 2012 · Journal of Stroke and Cerebrovascular Diseases
Early Adoption of Dabigatran and Its Dosing in US Patients With Atrial Fibrillation: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation
Benjamin Adam Steinberg, DaJuanicia N. Holmes, Jonathan Paul Piccini, Jack Ansell, Paul Chang, Gregg C. Fonarow, Bernard John Gersh, Kenneth W. Mahaffey, Peter Russell Kowey, Michael D. Ezekowitz et al. · 2013 · Journal of the American Heart Association
Secondary Prevention after Ischemic Stroke or Transient Ischemic Attack
Stephen M. Davis, Geoffrey Alan Donnan · 2012 · New England Journal of Medicine
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation
Jonas Oldgren, Ziad Hijazi, Johan Lindbäck, John Hunter Alexander, Stuart J. Connolly, John W. Eikelboom, Michael D. Ezekowitz, Christopher Bull Granger, Elaine M. Hylek, Renato D. Lópes et al. · 2016 · Circulation
Cerebral Amyloid Angiopathy
Christopher V. DeSimone, Jonathan Graff‐Radford, Majd A. El‐Harasis, Alejandro A. Rabinstein, Samuel J. Asirvatham, David R. Holmes · 2017 · Journal of the American College of Cardiology
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study
Walter Ageno, Maria Cristina Vedovati, Ander T. Cohen, Menno Volkert Huisman, Rupert Martin Bauersachs, Gualberto Gussoni, Cecilia Becattini, Giancarlo Agnelli · 2020 · Thrombosis and Haemostasis
Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis
Daniel Caldeira, Márcio Barra, Ana Teresa Santos, Daisy Abreu, Fausto José Pinto, Joaquim José Ferreira, João N. Costa · 2014 · Heart
Management of Bleeding With Non–Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal Agents
Christian Thomas Ruff, Robert Patrick Giugliano, Elliott Marshall Antman · 2016 · Circulation
Direct Oral Anticoagulants Compared to Vitamin K Antagonist for the Management of Left Ventricular Thrombus
Hansa Iqbal, Sam Straw, Thomas P. Craven, Katherine Stirling, Stephen Bentley Wheatcroft, Klaus K. Witte · 2020 · ESC Heart Failure
Patient outcomes using the European label for dabigatran
Andreas Clemens, Herbert Noack, Jorge Ferreira, Stuart J. Connolly, Salim Yusuf, Gregory Y.H. Lip · 2013 · Thrombosis and Haemostasis
Atrial high-rate episodes and stroke prevention
A. John Camm, EMMANUEL N. SIMANTIRAKIS, Andreas Goette, Gregory Y.H. Lip, Panos E. Vardas, Melanie Calvert, GREGORY I. CHLOUVERAKIS, Hans‐Christoph Diener, Paulus F. Kirchhof · 2016 · EP Europace
Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: A systematic review
Francis E. Ugowe, Larry R. Jackson, Kevin L. Thomas · 2018 · Heart Rhythm
Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice
Michael Fralick, Michael Colacci, Sebastian Schneeweiß, Krista F. Huybrechts, Kueiyu Joshua Lin, Joshua J. Gagne · 2020 · Annals of Internal Medicine
Antagonists of Vitamin K—Popular Coumarin Drugs and New Synthetic and Natural Coumarin Derivatives
Kinga Kasperkiewicz, Michal Blazej Ponczek, Jacek Owczarek, Piotr Guga, Elżbieta Budzisz · 2020 · Molecules
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation
Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, Gregory Y.H. Lip, Flemming Skjøth · 2014 · Thrombosis and Haemostasis
A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons
Deanna G. Brown, Eric C. Wilkerson, W. Elliot Love · 2014 · Journal of the American Academy of Dermatology
Calidad de la anticoagulación con antagonistas de la vitamina K en España: prevalencia de mal control y factores asociados
Manuel Anguita Sánchez, Vicente Bertoméu, Angel R. Cequier · 2015 · Revista Española de Cardiología
Dabigatran Etexilate and Risk of Myocardial Infarction, Other Cardiovascular Events, Major Bleeding, and All‐Cause Mortality: A Systematic Review and Meta‐analysis of Randomized Controlled Trials
Jonathan Douxfils, Fanny Buckinx, François Mullier, Valentine Minet, Véronique Rabenda, Jean‐Yves Reginster, Philippe Hainaut, Olivier Bruyère, Jean‐Michel Dogné · 2014 · Journal of the American Heart Association
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry
Michał Mazurek, Menno Volkert Huisman, Kenneth Jay Rothman, Miney Paquette, Christine Teutsch, Hans‐Christoph Diener, Sérgio Dubner, Jonathan L. Halperin, Chang Ma, Kristina Zint et al. · 2017 · Thrombosis and Haemostasis
Association Between Use of Pharmacokinetic‐Interacting Drugs and Effectiveness and Safety of Direct Acting Oral Anticoagulants: Nested Case‐Control Study
Naomi Gronich, Nili Stein, Mordechai Muszkat · 2021 · Clinical Pharmacology & Therapeutics
Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Meena P. Rao, Sigrun Halvorsen, DANIEL M. WOJDYLA, Laine Elliott Thomas, John Hunter Alexander, Elaine M. Hylek, Michael Hanna, Maria Cecilia Bahit, Renato D. Lópes, Raffaele De Caterina et al. · 2015 · Journal of the American Heart Association
Risk of Stroke or Systemic Embolism in Atrial Fibrillation Patients Treated With Warfarin: A Systematic Review and Meta-analysis
Albertsen, Ida Ehlers, Rasmussen, Lars Hvilsted, Overvad, Thure Filskov, Graungaard, Tina, Larsen, Torben Bjerregaard, Lip, Gregory Y.H. · 2013 · Stroke
Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)
Friberg, Leif, Engdahl, Johan, Frykman, Viveka, Svennberg, Emma, Levin, Lars-Åke, Rosenqvist, Mårten · 2013 · EP Europace
The New Oral Anticoagulants in Clinical Practice
Wilson I. Gonsalves, Rajiv K. Pruthi, Mrinal M. Patnaik · 2013 · Mayo Clinic Proceedings
Real-world evidence of stroke prevention in patients with nonvalvular atrial fibrillation in the United States: the REVISIT-US study
Craig Ian Coleman, Matthias Antz, Kevin Bowrin, Thomas Evers, Edgar P. Simard, Hendrik Bonnemeier, Riccardo Cappato · 2016 · Current Medical Research and Opinion
Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation
Ziad Hijazi, Jonas Oldgren, Agneta G Siegbahn, Lars C. Wallentin · 2016 · Clinical Chemistry
Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention
Maurizio Paciaroni, Giancarlo Agnelli, Valeria Caso, Giorgio Silvestrelli, David Julian Seiffge, Stefan T. Engelter, Gian Marco De Marchis, Alexandros A. Polymeris, Marialuisa Zedde, Shadi R. Yaghi et al. · 2019 · Stroke
Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants
Megan O. Nakashima, Heesun Joyce Rogers · 2014 · Blood Research
D‐dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation – observations from the ARISTOTLE trial
Christina Christersson, Lars C. Wallentin, Ulrika Andersson, John Hunter Alexander, Jack Ansell, Raffaele De Caterina, Bernard John Gersh, Christopher Bull Granger, M. Hanna, John David Horowitz et al. · 2014 · Journal of Thrombosis and Haemostasis
Risk of Atrial Fibrillation and Bleeding Diathesis Associated With Ibrutinib Treatment: A Systematic Review and Pooled Analysis of Four Randomized Controlled Trials
Seongseok Yun, Nicole D. Vincelette, Utkarsh H. Acharya, Ivo L Abraham · 2016 · Clinical Lymphoma Myeloma & Leukemia
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation
Paul Dorian, Thitima Kongnakorn, Hemant M. Phatak, Dale A. Rublee, Andreas Kuznik, Tereza Lanitis, Liu Lz, UH Iloeje, Luis G. Hernandez, Gregory Y.H. Lip · 2014 · European Heart Journal
Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis
Daniel Caldeira, Márcio Barra, Fausto José Pinto, Joaquim José Ferreira, João N. Costa · 2014 · Journal of Neurology
Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome
Scott C. Woller, Scott M. Stevens, David A. Kaplan, David Ware Branch, Valerie T. Aston, Emily L. Wilson, Heather M. Gallo, Eric Johnson, Matthew Thomas Rondina, James F. Lloyd et al. · 2015 · Clinical and Applied Thrombosis/Hemostasis
Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature
Virginie Dufrost, Jessie Risse, Stéphane Zuily, Denis G. Wahl · 2016 · Current Rheumatology Reports
Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study
Laila Stærk, Thomas Alexander Gerds, Gregory Y.H. Lip, Brice Ozenne, Anders Nissen Bonde, Morten Lamberts, Emil Loldrup Fosbøl, Christian Torp-Pedersen, Gunnar Gislason, Jonas Bjerring Olesen · 2017 · Journal of Internal Medicine
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation
Tze‐Fan Chao, Boyoung Joung, Yoshihide Takahashi, Toon Wei Lim, Eue‐Keun Choi, Yi‐Hsin Chan, Yutao Guo, Charn Sriratanasathavorn, Seil Oh, Ken Okumura et al. · 2021 · Journal of Arrhythmia
Amiodarone, Anticoagulation, and Clinical Events in Patients With Atrial Fibrillation
Greg Flaker, Renato D. Lópes, Elaine M. Hylek, DANIEL M. WOJDYLA, Laine Elliott Thomas, Sana M. Al‐Khatib, Renee M. Sullivan, Stefan Hans Hohnloser, David A. Garcia, Michael Hanna et al. · 2014 · Journal of the American College of Cardiology
Novel oral anticoagulants: clinical pharmacology, indications and practical considerations
Sebastian Harder, Jochen Graff · 2013 · European Journal of Clinical Pharmacology
Current use of direct oral anticoagulants for atrial fibrillation in Japan: Findings from the SAKURA AF Registry
Yasuo Okumura, Katsuaki Yokoyama, Naoya Matsumoto, Eizo Tachibana, Keiichiro Kuronuma, Koji Oiwa, Michiaki Matsumoto, Toshiaki Kojima, Shoji Hanada, Kazumiki Nomoto et al. · 2017 · Journal of Arrhythmia
Percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation: implantation and up to four years follow-up of the AMPLATZER Cardiac Plug
Santoro, Gennaro, Meucci, Francesco, Stolcova, Miroslava, Rezzaghi, Marco, Mori, Fabio, Palmieri, Cataldo, Paradossi, Umberto, Pastormerlo, Luigi Emilio, Rosso, Gabriele, Berti, Sergio · 2016 · EuroIntervention